Palazestrant
Product Specifications
CAS Number
2092925-89-6
Synonyms
OP-1250
Target
Estrogen/progestogen Receptor
Applications
Endocrinology & Hormones
Molecular Formula
C28H36FN3O
Additionnal Information
Palazestrant (OP-1250) is an orally bioavailable complete antagonist of estrogen receptor (ER) that blocks ER activity. It exhibits antiproliferative and antitumor activity in ER-positive (ER+) breast cancer models.
More Discoveries
Explore Other Products
Browse additional items from our catalog
bsm-62649R-BF350-01 20 µL
DTYMK Recombinant Antibody, AbBy Fluor™ 350 Conjugated
Sign In for Pricing
View Details 
bsm-62649R-BF350-02 100 µL
DTYMK Recombinant Antibody, AbBy Fluor™ 350 Conjugated
Sign In for Pricing
View Details MBS1457050-01 0.02 mg (E-Coli)
Recombinant Bradyrhizobium japonicum NADH-quinone oxidoreductase subunit B (nuoB)
Sign In for Pricing
View Details 
MBS1457050-02 0.1 mg (E-Coli)
Recombinant Bradyrhizobium japonicum NADH-quinone oxidoreductase subunit B (nuoB)
Sign In for Pricing
View Details MBS1457050-03 0.02 mg (Yeast)
Recombinant Bradyrhizobium japonicum NADH-quinone oxidoreductase subunit B (nuoB)
Sign In for Pricing
View Details MBS1457050-04 0.1 mg (Yeast)
Recombinant Bradyrhizobium japonicum NADH-quinone oxidoreductase subunit B (nuoB)
Sign In for Pricing
View Details